Analysis and contextual insights are available on OpenCVE Cloud.
No vendor fix or workaround currently provided.
Additional remediation guidance may be available on OpenCVE Cloud.
Tracking
Sign in to view the affected projects.
No advisories yet.
| Link | Providers |
|---|---|
| https://www.oracle.com/security-alerts/cspuaug2026.html |
|
Tue, 18 Aug 2026 21:15:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| Description | Vulnerability in the PeopleSoft Enterprise FIN Lease Administration product of Oracle PeopleSoft (component: Lease Administration). The supported version that is affected is 9.2. Difficult to exploit vulnerability allows low privileged attacker with logon to the infrastructure where PeopleSoft Enterprise FIN Lease Administration executes to compromise PeopleSoft Enterprise FIN Lease Administration. While the vulnerability is in PeopleSoft Enterprise FIN Lease Administration, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all PeopleSoft Enterprise FIN Lease Administration accessible data as well as unauthorized access to critical data or complete access to all PeopleSoft Enterprise FIN Lease Administration accessible data. CVSS 3.1 Base Score 7.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:N). | |
| First Time appeared |
Oracle
Oracle peoplesoft Enterprise Fin Lease Administration |
|
| CPEs | cpe:2.3:a:oracle:peoplesoft_enterprise_fin_lease_administration:9.2:*:*:*:*:*:*:* | |
| Vendors & Products |
Oracle
Oracle peoplesoft Enterprise Fin Lease Administration |
|
| References |
| |
| Metrics |
cvssV3_1
|
Status: PUBLISHED
Assigner: oracle
Published:
Updated: 2026-08-18T21:03:28.393Z
Reserved: 2026-08-04T22:06:34.616Z
Link: CVE-2026-71092
No data.
Status : Received
Published: 2026-08-18T21:18:09.450
Modified: 2026-08-18T21:18:09.450
Link: CVE-2026-71092
No data.
OpenCVE Enrichment
No data.
No weakness.